What Researchers Did
Researchers reported on the case of a 60-year-old woman with toxic epidermal necrolysis (TEN) who received hyperbaric oxygen treatment (HBOT).
What They Found
The patient underwent 5 sessions of hyperbaric oxygen treatment (HBOT) at 243.1 kPa. Desquamation stopped after the first session, and re-epithelisation began rapidly, leading to discharge after 14 days.
What This Means for Canadian Patients
Hyperbaric oxygen treatment might be considered as an adjunctive therapy for patients experiencing severe skin conditions like toxic epidermal necrolysis. While promising, this single case report suggests further research is needed to confirm its broader effectiveness and safety.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The primary limitation of this study is its design as a single case report, which prevents generalizable conclusions about treatment efficacy.